ArticleLeukemia research reports2026

Gilteritinib-associated hand-foot syndrome: a novel dermatologic reaction in refractory FLT3 Acute myeloid leukemia.

Jack T Seki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.